课题基金 / 基金详情

Ex vivo expansion of human cord blood Lin-CD34-cells using indian hedgehog stromal cells

Ex vivo expansion of human cord blood Lin-CD34-cells using indian hedgehog stromal cells
使用印度刺猬基质细胞体外扩增人脐带血 Lin-CD34-细胞
批准号:
17591003
负责人:
KOBUNE Masayoshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KOBUNE Masayoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transplantation of hematopoietic stem cells (HSCs) is usually based on intravenous injection, a complex process that requires circulation through blood, recognition and extravasation through bone marrow vasculature, and migration to a supportive microenvironment. However, some of HSCs including CB Lin-CD34- stem cells rarely engraft in bone marrow. We cocultured CB Lin-CD34- cells with human stromal cells in the presence of TPO, FL and SCF. As a result, cocultured CB Lin-CD34- cells remarkably expressed chemokine receptor CXCR4 with remarkable proliferative potential although CB Lin-CD34- cells undergo apoptosis without stromal free culture (Total cells, 92±10 vs. 1542±161(x10^3) ; CD34+ cells, 0±0 vs. 156±16 (x10^3) ; CFU-C, 192±46 vs. 120320±34762 ; CFU-Mix, 8±5 vs. 6513±3791 from five hundred thousand CB Lin-CD34- cells). Moreover, these cells acquired homing activity to BM and engrafted in NOD/SCID/IL2R _chain null mice for 24 weeks although Lin-CD34- cells cultured without human stromal cells hardly engrafted. Therefore, stromal interaction with CB Lin-CD34- cells confers the ability of engraftment to BM niche and responsiveness to hematopoietic growth factors. These findings may provide novel strategy of BM transplantation and utilization of CB Lin-CD34- fraction for ex vivo production of blood cells.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition
在无血清条件下在端粒化人基质细胞上扩增 CD34+ 细胞而不丧失红系分化潜能
DOI: --
发表时间: 2005
期刊: Int.J Hematol. 81,No 1
影响因子: --
作者: [Masayoshi Kobune]
通讯作者: Masayoshi Kobune
DOI: 10.1016/j.exphem.2007.03.005
发表时间: 2007-06-01
期刊: EXPERIMENTAL HEMATOLOGY
影响因子: 2.6
作者: [Kato, Junji, Kobune, Masayoshi, Niitsu, Yoshiro]
通讯作者: Niitsu, Yoshiro
DOI: 10.1016/j.ymthe.2004.09.020
发表时间: 2005-01-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者: [Kurozumi, K, Nakamura, K, Hamada, H]
通讯作者: Hamada, H
三輪血液病学
三和血液学
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [共同執筆 浅野茂隆, 池田康夫, 内山卓]
通讯作者: 内山卓
9
    Establishment of iron chelation therapy to inhibit the development of MDS
    • 批准号:
      24659466
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      KOBUNE Masayoshi
    • 依托单位:
    Development of dual targeting therapy for cancer stem cells and niche
    • 批准号:
      21591213
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      KOBUNE Masayoshi
    • 依托单位:
    海外基金